Vimarsana
Biggest News Aggregation in the World

Page 5 - Dan Forche News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Dan Forche. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Dan Forche Today - Breaking & Trending Today

PreludeDx™ Closes $20 Million in Funding to Advance Growth Initiatives and Development of Its Precision Medicine Portfolio - Vimarsana News

PreludeDx™ Closes $20 Million in Funding to Advance Growth Initiatives and Development of Its Precision Medicine Portfolio

/PRNewswire/-- Prelude Corporation (PreludeDx™), a leader in molecular diagnostics and precision medicine for early-stage breast cancer, today announced that...

PreludeDx™ Announces the Appointment of Derek J. Maetzold of Castle Biosciences to its Board of Directors - Vimarsana News

PreludeDx™ Announces the Appointment of Derek J. Maetzold of Castle Biosciences to its Board of Directors

PreludeDx™ Announces the Appointment of Derek J. Maetzold of Castle Biosciences to its Board of Directors - read this article along with other careers information, tips and advice on BioSpace

PreludeDx™ Announces the Appointment of Derek J. Maetzold of Castle Biosciences to its Board of Directors - Vimarsana News

PreludeDx™ Announces the Appointment of Derek J. Maetzold of Castle Biosciences to its Board of Directors

/PRNewswire/ -- Prelude Corporation (PreludeDx™), a leader in molecular diagnostics and precision medicine for early-stage breast cancer, today announced that...

PreludeDx™ DCISionRT® Predicts Radiation Benefit in Landmark Randomized SweDCIS Clinical Trial - Vimarsana News

PreludeDx™ DCISionRT® Predicts Radiation Benefit in Landmark Randomized SweDCIS Clinical Trial

/PRNewswire/ -- Prelude Corporation (PreludeDx™), a leader in molecular diagnostics and precision medicine for early-stage breast cancer, announced the...

DCISionRT® Demonstrates 40 Percent Change in Radiation Therapy Treatment Recommendation for DCIS Patients - Vimarsana News

DCISionRT® Demonstrates 40 Percent Change in Radiation Therapy Treatment Recommendation for DCIS Patients

/PRNewswire/ -- Prelude Corporation (PreludeDx™), a leader in molecular diagnostics and precision medicine for early-stage breast cancer, announced today it...